MedPath

BENZTROPINE MESYLATE

BENZTROPINE MESYLATE Tablets USP0.5 mg, 1 mg and 2 mg

Approved
Approval ID

17277751-785c-4ce6-a47f-6bc9ea072b9b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 29, 2022

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BENZTROPINE MESYLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6022
Application NumberANDA090168
Product Classification
M
Marketing Category
C73584
G
Generic Name
BENZTROPINE MESYLATE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 14, 2021
FDA Product Classification

INGREDIENTS (8)

BENZTROPINE MESYLATEActive
Quantity: 1 mg in 1 1
Code: WMJ8TL7510
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CORN OILInactive
Code: 8470G57WFM
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENZTROPINE MESYLATE - FDA Drug Approval Details